<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Representing the second cause of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related <z:hpo ids='HP_0011420'>death</z:hpo> after <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> in men and <z:hpo ids='HP_0003002'>breast cancer</z:hpo> in women, <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is a major health problem in Italy </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0001513'>Obesity</z:hpo> is reckoned to favor <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>; however, the underlying mechanisms are unclear </plain></SENT>
<SENT sid="2" pm="."><plain>Recently, a single nucleotide polymorphism (SNP) in the fat mass and <z:hpo ids='HP_0001513'>obesity</z:hpo> associated (FTO) gene was found to be significantly associated with <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>AIMS: To establish whether the FTO SNP rs9939609 may represent a risk factor for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and <z:mpath ids='MPATH_270'>adenoma</z:mpath> in the Italian population </plain></SENT>
<SENT sid="4" pm="."><plain>PATIENTS AND METHODS: 1,037 subjects were enrolled in the study and divided in 3 groups: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (341 pts., M/F=197/144, mean age=65.17±11.16 years), colorectal <z:mpath ids='MPATH_270'>adenoma</z:mpath> (385 pts., M/F=247/138, mean age=62.49±13.01 years), healthy controls (311 pts., M/F=150/161, mean age=57.31±13.84 years) </plain></SENT>
<SENT sid="5" pm="."><plain>DNA was extracted from whole blood, and stored frozen for rs9939609 genotyping by real-time PCR </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The frequency of the <z:hpo ids='HP_0001513'>obesity</z:hpo>-associated mutated A allele (AA+AT) on the FTO gene was 69.77% among controls, and 71.85% and 65.71% respectively among <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and <z:mpath ids='MPATH_491'>polyp</z:mpath> patients </plain></SENT>
<SENT sid="7" pm="."><plain>Compared to control subjects the AA+AT genotype had no significant effect on the risk for either <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (OR=1.106; CI 95%=0.788-1.550; p=0.561) or colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath> (OR=0.830; CI 95%=0.602-1.144; p=0.255) </plain></SENT>
<SENT sid="8" pm="."><plain>We did not observe any association between the AA genotype and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>/<z:mpath ids='MPATH_491'>polyp</z:mpath> localization and age at diagnosis </plain></SENT>
<SENT sid="9" pm="."><plain>As measured in a patient subset, carriership of the risk alleles did not reflect in a significantly altered BMI </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: The <z:hpo ids='HP_0001513'>obesity</z:hpo>-linked FTO variants do not play a significant role in modulating the <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> risk in the Italian population </plain></SENT>
</text></document>